Eli Lilly’s Mirikizumab Shows Promise in Long-Term Remission for Inflammatory Bowel Diseases

Eli Lilly and Company announced positive results from two Phase 3 studies of mirikizumab, showcasing its potential for sustained remission in both ulcerative colitis and Crohn’s disease. These findings, presented at the American College of Gastroenterology Annual Meeting, highlight the drug’s potential as a long-term treatment option for patients with inflammatory bowel diseases (IBDs).

Louise Thompson Embraces Fashion with Stoma Bag

Louise Thompson, former star of Made In Chelsea, defies societal norms by declaring her determination to wear any outfit she desires despite having a stoma bag. After suffering from ulcerative colitis for years, Thompson recently underwent a procedure to receive a stoma bag, which she has named “Winnie the bum bag.”

Scroll to Top